# A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

> **NCT00002452** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 30 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** L-756423
- **DRUG:** Indinavir sulfate

## Key facts

- **NCT ID:** NCT00002452
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002452, "A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00002452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*